Expression distribution, function and influencing factors of TIGIT, LAG-3 and TRENM2 in immune cells of patients with coronary heart disease

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2100045782

Enrollment

Unknown

Registered

2021-04-24

Start date

2021-05-01

Completion date

Unknown

Last updated

2021-12-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary heat disease

Interventions

case series:N/A

Eligibility

Sex/Gender

All

Age

18 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1.Aged > 18 years; 2.Patient with coronary heart disease.

Exclusion criteria

Exclusion criteria: The history of Alzheimer's disease, nervous system disease, blood disease, peptic ulcer, viral hepatitis, severe infection, autoimmune disease, tumor, severe liver dysfunction, long-term exposure to hormones and immunosuppressant, and incomplete data were identified.

Design outcomes

Primary

Measure	Time frame
Lymphocyte activating gene-3;T cell immunoglobulin and ITIM domains;Triggering Receptor Expressed on Myeloid Cells-2;	—

Countries

China

Contacts

Public ContactLi Wei

Affiliated Hospital of Guizhou Medical University

liwei249188@sina.com+86 13809482491

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026